glp-1 colorectal cancer death risk study november 2025 Could GLP-1s have an impact on colon risk? New data is promising. bit.ly/3NjW0wd Recent data suggests people taking drugs may develop cancer less often than those taking aspirin, a Glucagon-like peptide 1 receptor agonists

When taken correctly with strict adherence to the sublingual protocol, GLP-1 drops are designed to be therapeutically equivalent

If you fall into the second category, that does not mean you are doing something wrong

Meanwhile, they were significantly better than other GLP-1RAs in terms of efficacy

All medications, regardless of the class or subtype, have been standardized based on respective dose titration and its application related to the safety, efficacy and intended mechanism of action as they were researched and investigated, added Monique Richard, MS, RDN, LDN, a registered dietitian nutritionist and owner of Nutrition-In-Sight